Engineered Salmonella shrank tumors in animal models.

Solid tumors’ oxygen-starved cores resist chemotherapy but are exactly where anaerobic bacteria thrive.

The conjugate starves cancer cells of asparagine while flagellin protein trains immune cells to attack, researchers report.

Whether this platform survives human trials, unlike its predecessors, remains unknown.

Sources: Nature